$CLDI
Calidi Biotherapeutics, Inc.
XASE•Health Care•Biological Products, (No Diagnostic Substances)
$0.750
▼-2.55%-$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCalidi Biotherapeutics, Inc.
XASE•Health Care•Biological Products, (No Diagnostic Substances)
Why is CLDI down today? It is at $0.750 (-2.55%), and our scanner flagged it 14 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CLDI spikes, and full due diligence on CLDI — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CLDI 14 times in the last 30 days. Create a free account to track $CLDI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CLDI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CLDI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystListing deficiency / delisting risk, from the latest SEC filing. Read it →Across every filing on file, supply equal to 146.3% of the tradeable float is in play - 146.3% more can still be issued.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
3,685,849 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $9.9M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CLDI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CLDI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CLDI last traded at $0.750, down 2.55% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Calidi Biotherapeutics, Inc. (CLDI) is next expected to report earnings on Thursday, November 12, 2026, about 22 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CLDI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CLDI 14 times in the last 30 days.
CLDI (Calidi Biotherapeutics, Inc.) trades on XASE, with a market cap of about $2M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CLDI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CLDI discussion
Sign in to ask a question or join the discussion.